Hypertensive disease

Mineralys Phase 3 blood pressure pill data support potential FDA approval

1 month ago talkbio0Tagged Approved, Hypertensive disease, Launch-HTN, Uncontrolled, United States Food and Drug Administration

United States Food and Drug Administration, Launch-HTN, Uncontrolled, Hypertensive disease, Approved

Novo Nordisk Pursues $830 Million Fraud Claim Against KBP Biosciences Over Failed Hypertension Drug

2 months ago talkbio0Tagged Arbitrating, asset, Biosciences, Clinical Trials, Failure (biologic function), Fraud, Freezing, Hypertensive disease, kilobase pairs, Nordisk, Ocedurenone

Novo Nordisk, KBP Biosciences, ocedurenone, fraud, asset freeze, clinical trial failure, hypertension drug, arbitration

NFL Legend Jerome Bettis Joins CDC Foundation’s “Live to the Beat” Campaign to Tackle Heart Health in Black Community

3 months ago talkbio0Tagged beat, Bettis, Black Populations, Cardiovascular Diseases, Centers for Disease Control and Prevention (U.S.), Community, Foundations, heart health, Hypertensive disease, Jerome, NEFL gene

Jerome Bettis, CDC Foundation, Live to the Beat, cardiovascular disease, Black community, hypertension, heart health, NFL

Idorsia’s Restructuring Efforts Continue: Layoffs On Track Despite Delayed Sale of Hypertension Drug Tryvio

4 months ago talkbio0Tagged aprocitentan, cost-saving measures, financial sustainability, Hypertensive disease, Idorsia, layoffs, restructuring, Tryvio

Idorsia, Restructuring, Layoffs, Tryvio, Hypertension drug, Aprocitentan, Cost-saving measures, Financial sustainability

Novo Nordisk Terminates Development of Kidney Disease Drug Ocedurenone After Phase 3 Failure

6 months ago talkbio0Tagged CLARION-CKD, Drug Development, Failure (biologic function), Hypertensive disease, Kidney Diseases, Nordisk, Ocedurenone, Phase 3 trial

Novo Nordisk, ocedurenone, kidney disease, hypertension, Phase 3 trial, CLARION-CKD, drug development failure

CMS Approves Transitional Pass-Through Payments for Renal Denervation Systems from Medtronic and Recor Medical

6 months ago talkbio0Tagged Hypertensive disease, Medtronic, Myasthenic Syndromes, Congenital, Payments, Recor Medical, Renal Denervation Systems, Transitional cell morphology

Renal Denervation Systems, CMS, Transitional Pass-Through Payments, Medtronic, Recor Medical, Hypertension Treatment

George Medicines Unveils Promising Low-Dose Triple Combination Pill for Hypertension Management

8 months ago talkbio0Tagged control of blood pressure, George Medicines, GMRx2, Hypertensive disease, Low-Dose Treatment, Triplicate

Hypertension, Triple Combination Pill, Low-Dose, Blood Pressure Control, GMRx2, George Medicines

Evaluating the Impact of a Dose-Optimization App on Zestril Efficacy for Hypertension Management

11 months ago talkbio0Tagged blood pressure management, closed-loop testing, Dose-Optimization, Effectiveness, Hypertensive disease, Zestril

Zestril, hypertension, dose-optimization, app, closed-loop testing, efficacy, blood pressure management.

Roche and Alnylam’s Hypertension Hopeful Zilebesiran Shows Promising Results in Combination Therapy Trial

1 year ago talkbio0Tagged Alnylam, Angiotensinogen, Combined Modality Therapy, control of blood pressure, Hypertensive disease, Intravascular systolic:Pressure:Point in time:Arterial system:Quantitative, RNA Interference, Roche (company), Safety, Zilebesiran

Roche, Alnylam, Zilebesiran, Hypertension, Combination Therapy, Phase 2 Trial, Blood Pressure Control, AngioTensinogen (AGT), RNA Interference (RNAi) Therapeutic, Significant Reductions in Systolic Blood Pressure, Encouraging Safety Profile